Differences in fibrin fiber diameters in healthy individuals and thromboembolic ischemic stroke patients

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 8, 2011, Pages 696-700

  Pretorius, Etheresia ^a   Steyn, Helena ^a   Engelbrecht, Mia ^a   Swanepoel, Albe C ^a   Oberholzer, Hester M ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Fiber diameters; Fibrin networks; Thromboembolic stroke

Indexed keywords

FIBRIN;

ARTICLE; BRAIN ISCHEMIA; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; STROKE; STUDENT T TEST; THROMBOEMBOLISM;

CASE-CONTROL STUDIES; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; SOUTH AFRICA; STROKE; THROMBOEMBOLISM;

EID: 84855201578     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834bdb32     Document Type: Article

References (16)

1. Marsh JD, Keyrouz SG. Stroke prevention and treatment. J Am Coll Cardiol 2010; 56:683-691.
2. Sandercock PA, Counsell C, Kamal AK. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2008; 4:CD000024.
3. Kawai H, Yuki S, Sugimoto J, Tamao Y. Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J Pharmacol Exp Ther 1996; 278:780-785. (Pubitemid 27167046)
4. Morris DC, Zhang L, Zhang ZG, Lu M, Berens KL, Brown PM, et al. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke. Stroke 2001; 32:2635-2640. (Pubitemid 33055318)
5. Matijevic N, Wu KK. Hypercoagulable states and strokes. Curr Atheroscler Rep 2006; 8:324-329. (Pubitemid 44043651)
6. Park JS, Park SS, Koh EJ, Eun JP, Choi HY. Treatment for patients with acute ischemic stroke presenting beyond six hours of ischemic symptom onset: effectiveness of intravenous direct thrombin inhibitor, argatroban. J Korean Neurosurg Soc 2010; 47:258-264.
7. Vucković BA, Djerić MJ, Ilić TA, Canak VB, Kojić-Damjanov SLj, Zarkov MG, Cabarkapa VS. Fibrinolytic parameters, lipid status and lipoprotein(a) in ischemic stroke patients. Srp Arh Celok Lek 2010; 138 (Suppl 1):12-17.
8. Undas A, Podolec P, Zawilska K, Pieculewicz M, Jedliń ski I, Stépień E, et al. Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke. Stroke 2009; 40:1499-1501.
9. Pretorius E, Swanepoel AC, Oberholzer HM, Van der Spuy WJ, Duim W, Wessels PF. A descriptive investigation of the ultrastructure of fibrin networks in thrombo-embolic ischemic stroke. J Thromb Thrombolysis 2011; 31:507-513.
10. Pretorius E, Oberholzer HM, Van der Spuy WJ, Meiring JH. The changed ultrastructure of fibrin networks during use of oral contraception and hormone replacement. J Thromb Thrombolysis 2010; 30:502-506.
11. Pretorius E, Oberholzer HM, Van der Spuy WJ, Meiring JH. Smoking and coagulation: the sticky fibrin phenomenon. Ultrastruct Pathol 2010; 34:236-239.
12. Pretorius E, Vieira WA, Oberholzer HM, Auer REJ. Comparative scanning electron microscopy of platelets and fibrin networks of humans and different animals. Int J Morphol 2009; 27:69-76.
13. Campbell RA, Overmyer KA, Selzman CH, Sheriden BC, Wolberg AS. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood 2009; 114:4886-4896.
14. Undas A, Slowik A, Wolkow P, Szczudlik A, Tracz W. Fibrin clot properties in acute ischemic stroke: relation to neurological deficit. Thromb Res 2010; 125:357-361.
15. Minnerup J, Kleinschnitz C. Visualization of clot composition in ischemic stroke: do we get what we see? Stroke 2011; 42:1193-1194
16. Weisel JW. Structure of fibrin: impact on clot stability. J Thromb Haemost 2007; 1:116-124. (Pubitemid 46958824)